Post-earnings recap
Reported
Tue, Feb 6, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The strong EPS performance indicates that Haemonetics Corp is managing its costs effectively and generating better profits than expected. The stock's 9.35% increase reflects investor confidence following this positive surprise. However, the lack of revenue data and forward guidance may leave some investors cautious about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | +35.54% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the earnings beat, highlighting their commitment to improving operational efficiencies. They maintained a cautious outlook without providing specific guidance.
We are pleased with our EPS performance this quarter.
Our focus remains on driving operational efficiencies.